Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Medical Microbiology"
DOI: 10.1099/jmm.0.001372
Abstract: Introduction The ID NOW is FDA approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of symptom onset for COVID-19 if tested within 1 h of specimen collection. Gap statement Clinical data… read more here.
Keywords: abbott among; study; performance abbott; performance ... See more keywords